Affiliation:
1. Department of Pharmacy, Islamic University, Kushtia, Bangladesh
2. Department of Computer Science & Engineering, Prime University, Dhaka, Bangladesh
3. Department of Information & Communication Technology, Islamic University, Kushtia, Bangladesh
Abstract
The COVID-19 coronavirus, which primarily affects the lungs, is the source of the disease known as SARS-CoV-2. According to “Smoking and COVID-19: a scoping review,” about 32% of smokers had a severe case of COVID-19 pneumonia at their admission time and 15% of non-smokers had this case of COVID-19 pneumonia. We were able to determine which genes were expressed differently in each group by comparing the expression of gene transcriptomic datasets of COVID-19 patients, smokers, and healthy controls. In all, 37 dysregulated genes are common in COVID-19 patients and smokers, according to our analysis. We have applied all important methods namely protein-protein interaction, hub-protein interaction, drug-protein interaction, tf-gene interaction, and gene-MiRNA interaction of bioinformatics to analyze to understand deeply the connection between both smoking and COVID-19 severity. We have also analyzed Pathways and Gene Ontology where 5 significant signaling pathways were validated with previous literature. Also, we verified 7 hub-proteins, and finally, we validated a total of 7 drugs with the previous study.
Subject
Applied Mathematics,Computational Mathematics,Computer Science Applications,Molecular Biology,Biochemistry
Reference123 articles.
1. COVID‐19: Virology, biology and novel laboratory diagnosis
2. World Health Organization. Smoking and COVID-19. Scientific brief. Published June 30, 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Smoking-2020.2
3. World Health Organization. SARS-CoV-2. 2022. Smoking and COVID-19 (who.int).
4. Covid-19: True global death toll from pandemic is almost 15 million, says WHO
5. Diagnostics for SARS-CoV-2 infections